Ghazi H O, Erturk M, Stannard L M, Faulkner M, Potter C W, Jennings R
Department of Medical Microbiology, University of Sheffield Medical School, UK.
Arch Virol. 1995;140(6):1015-31. doi: 10.1007/BF01315412.
Immunostimulating complexes (ISCOMs) were prepared with mixtures of antigens from influenza A virus (A/PR/8/34 or A/Sichuan/2/87) and herpes simplex virus type 1 (HSV-1), and were characterised by enzyme linked immunosorbent assay (ELISA) and electron microscopy using double-labelling immunogold techniques employing monoclonal antibodies to influenza or HSV-1 glycoproteins. The immunogenicity of the mixed antigen ISCOMs was evaluated in mice, following administration by the subcutaneous route, by measuring the total and subclass IgG antibody responses. Protection of these animals against challenge with live influenza A/Sichuan virus or live HSV-1, was compared with that induced by immunization with aqueous mixed antigen preparations. It was found that relatively high humoral responses to both influenza and HSV antigens, and increased levels of protection to both influenza and HSV viruses were elicited in mice receiving the mixed antigen ISCOM preparation compared to those observed in animals receiving the mixed aqueous subunit preparation. The findings also indicate that antigens from more than one virus can be used in an ISCOM formulation to produce immunity and protection.
免疫刺激复合物(ISCOMs)是用甲型流感病毒(A/PR/8/34或A/四川/2/87)和单纯疱疹病毒1型(HSV-1)的抗原混合物制备的,并通过酶联免疫吸附测定(ELISA)以及使用针对流感或HSV-1糖蛋白的单克隆抗体的双标记免疫金技术进行电子显微镜表征。通过皮下途径给药后,通过测量总IgG抗体反应和亚类IgG抗体反应,在小鼠中评估混合抗原ISCOMs的免疫原性。将这些动物针对甲型流感病毒/四川活病毒或HSV-1活病毒攻击的保护作用与用混合抗原水性制剂免疫诱导的保护作用进行比较。结果发现,与接受混合水性亚单位制剂的动物相比,接受混合抗原ISCOM制剂的小鼠对流感和HSV抗原均产生了相对较高的体液反应,并且对流感和HSV病毒的保护水平有所提高。这些发现还表明,来自不止一种病毒的抗原可用于ISCOM制剂中以产生免疫和保护作用。